بررسی ترکیب بیکولاتید و رالوکسیفن برای بیماران مبتلا به سرطان پروستات مقاوم به کاستاریکا

The results of the present study have shown that bicalutamide/raloxifene treatment is well tolerated. However, limited clinical activity occurred in men with CRPC who had previously undergone secondary hormonal therapy or chemotherapy.